Medical Diagnostics & Clinical Scoring

TIMI Risk Score for STEMI

Calculate the TIMI Risk Score for STEMI patients to predict 30-day mortality risk and guide urgent reperfusion strategies.

TIMI STEMI Score: 0/14

Calculated locally in your browser. Fast, secure, and private.

The TIMI Risk Score for STEMI (ST-Elevation Myocardial Infarction) was developed by the Thrombolysis in Myocardial Infarction study group to rapidly stratify the mortality risk of patients suffering a massive heart attack.

The Variables

The score is built upon easily obtainable clinical variables available within minutes of the patient arriving at the hospital:

  • Age: The heaviest weighted factor. (65-74 gets 2 points, ≥ 75 gets 3 points).
  • Vitals: Systolic BP < 100 mmHg (3 points) and Heart Rate > 100 bpm (2 points) indicate cardiogenic shock and heavily spike the score.
  • Killip Class: Presence of heart failure (rales, pulmonary edema, shock) adds 2 points.
  • History: Diabetes, hypertension, or prior angina adds 1 point.
  • ECG: Anterior STEMI or new LBBB adds 1 point.
  • Time/Weight: Delayed treatment (>4 hours) and low body weight (<67 kg) add 1 point each.

TIMI Score = Sum of points derived from patient age, historical factors, and presentation vital signs/ECG.

Where:
Score=
Ranks from 0 to 14. Higher scores linearly correlate with massive increases in 30-day mortality.

Mortality Prediction

The resulting score (0 to 14) corresponds to a historically validated 30-day mortality rate. A score of 0 has a mortality of <1%, while a score >8 predicts a mortality rate exceeding 35%. This objective quantification is crucial for guiding aggressive therapies (like IABP placement) and having realistic discussions with families.

Frequently Asked Questions

The Thrombolysis in Myocardial Infarction (TIMI) Risk Score for STEMI is a prognostic tool used to predict 30-day mortality in patients presenting with an ST-elevation myocardial infarction.

Yes, they are completely distinct scores. The STEMI score focuses heavily on vital signs (hypotension, tachycardia), age, and time to treatment, whereas the NSTEMI score focuses more on aspirin use, cardiac markers, and severe angina.

It helps clinicians identify the highest-risk patients who require the most aggressive reperfusion strategies and the closest ICU monitoring, as their 30-day mortality risk can exceed 35%.